01/08/2026
New UCSF research published in Open Forum Infectious Diseases addresses a key barrier in hepatitis C elimination efforts: confirming cure in populations that face challenges returning for follow-up care.
The study examines whether a cure could be reliably confirmed sooner, particularly in community-based, non-clinical settings serving people who inject drugs. “This study shows that we can simplify hepatitis C care without compromising accuracy,” said Meghan Morris, PhD, MPH, senior author and professor of Epidemiology & Biostatistics.
Congratulations to Meghan Morris and her research team on this impactful contribution to public health practice.
🔗 Published study: https://academic.oup.com/ofid/article/13/1/ofaf737/8381814?login=true
🔗 UCSF article: https://www.ucsf.edu/news/2025/12/431256/can-cure-hepatitis-c-be-confirmed-sooner-after-treatment
In a community cohort of people who inject drugs, HCV RNA results at treatment completion and four weeks post treatment completion accurately predicted SVR